1-5 of 5
Catherine M Gavile
Close
Sort by
Journal Articles

A Role for Syntenin-1 in Multiple Myeloma Cell Survival

Tyler Moser-Katz, Catherine M. Gavile, Benjamin G Barwick, PhD, Sagar Lonial, MD, Lawrence H. Boise, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1008.
https://doi.org/10.1182/blood-2018-99-113594
Published: 2018
Journal Articles

Ablation of CD28-86 Signaling Results in Induction of Both Caspase-Dependent and Caspase-Independent Cell Death in Myeloma Cells

Catherine M Gavile, Ajay K. Nooka, MD MPH, Sagar Lonial, MD, Kelvin P Lee, MD, Lawrence H. Boise, PhD
Journal: Blood
Blood (2014) 124 (21): 4726.
https://doi.org/10.1182/blood.V124.21.4726.4726
Published: 2014
Journal Articles

CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma

Megan E. Murray, Catherine M. Gavile, Jayakumar R. Nair, Chandana Koorella, Louise M. Carlson, Daniela Buac, Adam Utley, Marta Chesi, P. Leif Bergsagel, Lawrence H. Boise, Kelvin P. Lee
Journal: Blood
Blood (2014) 123 (24): 3770–3779.
https://doi.org/10.1182/blood-2013-10-530964
Published: 2014
Includes: Supplemental data
Journal Articles

CD28 and CD86 Regulate Integrin Surface Expression In Multiple Myeloma

Catherine M Gavile, BS, David Egas, Gregory H Doho, MS, Sagar Lonial, M.D., Kelvin P Lee, MD, Lawrence H. Boise, PhD
Journal: Blood
Blood (2013) 122 (21): 4450.
https://doi.org/10.1182/blood.V122.21.4450.4450
Published: 2013
Journal Articles

CD28 and CD86 Are Necessary for Myeloma Cell Survival.

Catherine M Gavile, BS, Jayakumar R Nair, Ph.D., Kelvin P Lee, MD, Sagar Lonial, MD, Lawrence H. Boise, PhD
Journal: Blood
Blood (2012) 120 (21): 2946.
https://doi.org/10.1182/blood.V120.21.2946.2946
Published: 2012